Compare PRTC & CVGW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PRTC | CVGW |
|---|---|---|
| Founded | 2015 | 1924 |
| Country | | US |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Specialty Foods |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 464.3M | 466.0M |
| IPO Year | N/A | 2002 |
| Metric | PRTC | CVGW |
|---|---|---|
| Price | $17.65 | $26.75 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $33.50 |
| AVG Volume (30 Days) | 2.0K | ★ 486.0K |
| Earning Date | 01-01-0001 | 04-30-2026 |
| Dividend Yield | N/A | ★ 3.01% |
| EPS Growth | N/A | ★ 1950.00 |
| EPS | N/A | ★ 1.11 |
| Revenue | N/A | ★ $648,434,000.00 |
| Revenue This Year | N/A | $3.49 |
| Revenue Next Year | N/A | $11.23 |
| P/E Ratio | ★ $8.09 | $23.99 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $13.30 | $18.40 |
| 52 Week High | $20.00 | $28.72 |
| Indicator | PRTC | CVGW |
|---|---|---|
| Relative Strength Index (RSI) | 46.90 | 74.32 |
| Support Level | $17.46 | $24.92 |
| Resistance Level | $18.00 | $26.28 |
| Average True Range (ATR) | 0.43 | 0.55 |
| MACD | -0.18 | 0.02 |
| Stochastic Oscillator | 16.83 | 97.56 |
PureTech Health PLC, together with its subsidiaries, is a clinical-stage biopharma company developing medicines to modulate the adaptive human system. The company is focused on developing and commercializing differentiated medicines for devastating diseases, including inflammatory, immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, and neurological and neuropsychological disorders, among others. Its drug development pipeline consists of Deupirfenidone (LYT-100), for the potential treatment of idiopathic pulmonary fibrosis (IPF), LYT-200, SPT-300, an oral drug for depressive disorder, SPT-320, and others. The company's operating segments include Parent Companies & Other, which derives key revenue, Wholly-Owned Programs, and Controlled Founded Entities.
Calavo Growers Inc is engaged in the sourcing, packing, and distribution of fresh avocados, tomatoes, and papayas, and the processing of guacamole and other avocado products. The company delivers products to retail grocers, club and mass-merchandise stores, foodservice operators, and wholesalers, sourcing avocados from California, Mexico, and other key growing regions. Its operations include sorting, packing, ripening, and shipping fresh produce, and processing and packaging fresh and frozen guacamole. The company operates through two segments: Fresh, including avocados, tomatoes, papayas, and other fresh produce products, and Prepared, including guacamole and avocado pulp, with the majority of revenue generated from the Fresh segment and geographically from the United States.